Work

Review on Artificial Intelligence (AI) in Pharmaceutical Field

Year: 2026
Type: article
Abstract: Artificial Intelligence (AI) has become a powerful and transformative tool in pharmaceutical sciences, providing advanced approaches to overcome traditional challenges in drug discovery, development, formulation, and clinical decision- making. The pharmaceutical sector is under continuous pressure to shorten development timelines, reduce costs, and improve the success rate of new drug candidates while ensuring safety and therapeutic effectiveness. AI-based technologies such as machine learning (ML), deep learning (DL), natural language processing (NLP), and generative modeling have significantly improved the processes of target identification, molecular interaction prediction, and lead optimization. These computational techniques allow rapid screening of extensive chemical databases, accurate prediction of pharmacokinetic and toxicological (ADMET) profiles, simulation of virtual clinical trials, and implementation of personalized treatment strategies using real-world data. Furthermore, AI contributes to pharmaceutical formulation development by predicting drug–excipient compatibility, optimizing manufacturing parameters, and maintaining product quality through advanced Quality by Design (QbD) frameworks. In pharmacovigilance, AI enhances the monitoring of drug safety by enabling automated adverse event detection, signal generation, and risk evaluation through analysis of electronic health records, clinical databases, and social media sources. Although AI offers significant advantages, its widespread adoption faces challenges including data security issues, lack of algorithm transparency, regulatory uncertainties, and the requirement for robust, high-quality datasets. This review outlines the present applications, recent technological developments, benefits, and limitations of AI in pharmaceutical research, emphasizing its expanding role in driving innovation and improving global healthcare outcomes.
Language: English
Subfield: Drug Discovery
Open Access status: green
OpenAlex ID: W7130937748
FWCI: 3.163
Cites:
Cited by: 2
Related to: 10